CA 125 (Ovaria CA) ECLIA
Starts at ₱ 1,900
The CA 125 test measures a protein that may be elevated in ovarian cancer, as well as conditions like endometriosis or pelvic inflammation. Using advanced ECLIA technology, it delivers accurate and sensitive results.
While not used for diagnosis alone, it’s valuable for tracking ovarian cancer treatment, detecting recurrence, and evaluating related symptoms. It may also be recommended for those with a family history or genetic risk of ovarian cancer.
Participating Providers
Shinagawa Diagnostic and Preventive Care
Hi-Precision
Hi-Precision Cebu
Hi Precision PlusWhy Patients Choose Us
Find a Clinic Near YouBook your services online for over 100+ partner clinics nationwide
Fast & Easy BookingSkip the lines with easy, hassle-free booking
Online-Exclusive PricesGet special prices when you book online—save on your health needs
Additional Information
Test Requirements
- No fasting required.
- Do not take Biotin (Vitamin B7) for 8 hours prior to extraction.
How to Claim
FREE Hati Health Concierge Service
Related Products
Related Categories
More About This Product
Find best CA 125 (Ovaria CA) ECLIA price in the Philippines. The CA 125 (Ovarian CA) ECLIA test is a crucial blood test that measures the CA 125 protein levels, which can indicate the presence of ovarian cancer when elevated. Using cutting-edge ElectroChemiluminescence Immunoassay (ECLIA) technology, this test is recognized for its sensitive and accurate results. While elevated levels can suggest ovarian cancer, they may also arise due to conditions like endometriosis, pelvic inflammatory disease, or abdominal pain.
This test is particularly beneficial for monitoring treatment progress in patients undergoing chemotherapy for ovarian cancer. It is also used to evaluate various symptoms such as abnormal bleeding or fatigue, especially in women postmenopause or those with a family history of ovarian cancer. Though not a definitive diagnostic tool, the CA 125 test plays an essential role in assessing health risks related to ovarian abnormalities, making it a vital part of general wellness evaluations. Ensuring early detection of potential risks can significantly benefit treatment outcomes.